Bundibugyo Ebola Explained: Why Existing Vaccines Don't Work and What Comes Next
An outbreak of the Bundibugyo Ebola virus in the Democratic Republic of the Congo has highlighted a lack of approved vaccines or therapeutics for this specific strain. Researchers are currently evaluating three promising candidates, including monoclonal antibodies, to address the limitations of existing treatments designed for the Zaire strain.
A particular silence settles over a treatment team when the staff learns the strain of Ebola, they are treating has no approved vaccine or treatment. This Ebola outbreak announced itself in early May. A hospital in the northeastern Democratic Republic of the Congo (DRC) identified a cluster of severe illness among its own staff. 1 It wasn’t until the middle of May that the specific strain was identified as the Bundibugyo virus, the cause of Bundibugyo virus disease (BVD).
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in